Carbonyl Reductase 1 Polyclonal Antibody

The protein encoded by CBR1 (carbonyl reductase 1) belongs to the short-chain dehydrogenases/reductases (SDR) family, which function as NADPH-dependent oxidoreductases having wide specificity for carbonyl compounds, such as quinones, prostaglandins, and various xenobiotics. Alternatively spliced transcript variants have been found for CBR1.

The Carbonyl Reductase 1 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and quantification of Carbonyl Reductase 1 (CBR1) protein in various biological samples. This antibody has been extensively validated and exhibits exceptional sensitivity and specificity, making it an ideal choice for a wide range of research applications.

CBR1 is a crucial enzyme involved in the metabolism of various endogenous and exogenous compounds, including drugs, xenobiotics, and reactive carbonyl compounds. It plays a significant role in the detoxification and elimination of these compounds, making it an essential target for studying drug metabolism, toxicology, and oxidative stress-related diseases.

The Carbonyl Reductase 1 Polyclonal Antibody has been produced using high-quality immunogens and advanced immunization techniques, ensuring its superior performance and reliability. It has been rigorously tested against a panel of relevant samples to ensure its specificity and minimal cross-reactivity with other proteins.

This antibody offers numerous advantages, including its versatility in various applications such as Western blotting, immunohistochemistry, and immunofluorescence. It exhibits a strong signal with low background noise, enabling accurate and reproducible results. Additionally, it is compatible with a wide range of sample types, including cell lysates, tissue extracts, and biological fluids.

The Carbonyl Reductase 1 Polyclonal Antibody is supplied as a ready-to-use solution, eliminating the need for time-consuming and complex preparation steps. It is provided in a convenient format, allowing for easy storage and handling.

In summary, the Carbonyl Reductase 1 Polyclonal Antibody is a highly reliable and specific tool for the detection and quantification of CBR1 protein. Its exceptional sensitivity, specificity, and versatility make it an invaluable asset for researchers in the fields of drug metabolism, toxicology, and oxidative stress-related diseases.